New combo therapy aims to control hard-to-treat multiple myeloma
NCT ID NCT05372354
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 37 times
Summary
This study is for people with multiple myeloma that has returned or stopped responding to treatment. It tests a new drug, CC-92480, combined with other therapies to see if it is safe and works. About 260 adults will take part. The goal is to find the best dose and check how well the combination controls the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Alberta Health Services AHS - Foothills Medical Centre FMC
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
Contact Phone: •••-•••-••••
-
Churchill Hospital
RECRUITINGOxford, Oxfordshire, OX3 7LE, United Kingdom
Contact Phone: •••-•••-••••
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-••••
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
Contact Phone: •••-•••-••••
-
Hospital Universitario Marques de Valdecilla
RECRUITINGSantander, 39008, Spain
Contact Phone: •••-•••-••••
-
ICO - Hospital Germans Trias i Pujol
RECRUITINGBarcelona, 08026, Spain
Contact Phone: •••-•••-••••
-
John Theurer Cancer Center at Hackensack UMC
RECRUITINGHackensack, New Jersey, 07601, United States
Contact Phone: •••-•••-••••
-
Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-••••
-
Local Institution - 0001
WITHDRAWNLeicester, Leicestershire, LE1 5WW, United Kingdom
-
Local Institution - 0014
WITHDRAWNLiverpool, Merseyside, L7 8YA, United Kingdom
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10021, United States
Contact
-
NIHR UCLH Clinical Research Facility
RECRUITINGLondon, W1T 7HA, United Kingdom
Contact Phone: •••-•••-••••
-
Oslo University Hospital
RECRUITINGOslo, Outside US and Canada, 0450, Norway
Contact Phone: •••-•••-••••
-
The Christie NHS Foundation Trust
RECRUITINGManchester, Greater Manchester, M20 4BX, United Kingdom
Contact Phone: •••-•••-••••
-
UAB Comprehensive Cancer Center
RECRUITINGBirmingham, Alabama, 35249, United States
Contact Phone: •••-•••-••••
-
University Health Network UHN - Princess Margaret Hospital PMH
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-••••
-
University of Alberta - Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
Contact Phone: •••-•••-••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.